SEC Form 4 · accession 0001645627-17-000093
ENDONOVO THERAPEUTICS, INC. · ENDV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Scott Mann
Officer — President · 10% Owner
Period of report
Jul 13, 2014
Accepted (ET)
Jul 18, 2017 · 3:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001528172
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 13, 2017 | P | 1,500 | $0.029 | A | 21,571,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.028 | A | 21,573,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.0278 | A | 21,575,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.0288 | A | 21,577,849 | D | |
| Common Stock | Jul 13, 2017 | P | 5,000 | $0.0271 | A | 21,582,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.0287 | A | 21,584,849 | D | |
| Common Stock | Jul 13, 2017 | P | 5,000 | $0.027 | A | 21,589,849 | D | |
| Common Stock | Jul 13, 2017 | P | 5,000 | $0.027 | A | 21,594,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.027 | A | 21,596,849 | D | |
| Common Stock | Jul 13, 2017 | P | 10,000 | $0.026 | A | 21,606,849 | D | |
| Common Stock | Jul 13, 2017 | P | 5,000 | $0.0269 | A | 21,611,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.027 | A | 21,613,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.0268 | A | 21,615,849 | D | |
| Common Stock | Jul 13, 2017 | P | 5,000 | $0.0269 | A | 21,620,849 | D | |
| Common Stock | Jul 13, 2017 | P | 2,000 | $0.027 | A | 21,622,849 | D | |
| Common Stock | Jul 14, 2017 | P | 3,500 | $0.0269 | A | 21,626,349 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.0269 | A | 21,628,349 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.025 | A | 21,630,349 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.0264 | A | 21,632,349 | D | |
| Common Stock | Jul 14, 2017 | P | 5,000 | $0.0259 | A | 21,637,349 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.0259 | A | 21,639,349 | D | |
| Common Stock | Jul 14, 2017 | P | 770 | $0.0259 | A | 21,640,119 | D | |
| Common Stock | Jul 14, 2017 | P | 1,000 | $0.0259 | A | 21,641,119 | D | |
| Common Stock | Jul 14, 2017 | P | 1,000 | $0.0259 | A | 21,642,119 | D | |
| Common Stock | Jul 14, 2017 | P | 11,000 | $0.0259 | A | 21,653,119 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.026 | A | 21,655,119 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.026 | A | 21,657,119 | D | |
| Common Stock | Jul 14, 2017 | P | 5,000 | $0.026 | A | 21,662,119 | D | |
| Common Stock | Jul 14, 2017 | P | 2,000 | $0.0264 | A | 21,664,119 | D | |
| Common Stock | Jul 14, 2017 | P | 5,000 | $0.026 | A | 21,669,119 | D |
Table II — derivative securities
No Table II lines on this filing.